Literature DB >> 1482938

Drug delivery optimization through Bayesian networks.

R Bellazzi1.   

Abstract

This paper describes how Bayesian Networks can be used in combination with compartmental models to plan Recombinant Human Erythropoietin (r-HuEPO) delivery in the treatment of anemia of chronic uremic patients. Past measurements of hematocrit or hemoglobin concentration in a patient during the therapy can be exploited to adjust the parameters of a compartmental model of the erythropoiesis. This adaptive process allows more accurate patient-specific predictions, and hence a more rational dosage planning. We describe a drug delivery optimization protocol, based on our approach. Some results obtained on real data are presented.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1482938      PMCID: PMC2248059     

Source DB:  PubMed          Journal:  Proc Annu Symp Comput Appl Med Care        ISSN: 0195-4210


  5 in total

1.  GAMEES: a probabilistic environment for expert systems.

Authors:  R Bellazzi; S Quaglini; C Berzuini; M Stefanelli
Journal:  Comput Methods Programs Biomed       Date:  1991-07       Impact factor: 5.428

2.  Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharm Sci       Date:  1982-12       Impact factor: 3.534

3.  A mathematical model of iron metabolism.

Authors:  P C Franzone; A Paganuzzi; M Stefanelli
Journal:  J Math Biol       Date:  1982       Impact factor: 2.259

4.  A pharmacodynamic model of erythropoietin therapy for uremic anemia.

Authors:  D E Uehlinger; F A Gotch; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1992-01       Impact factor: 6.875

Review 5.  Epoetin: human recombinant erythropoietin.

Authors:  K K Flaharty; A M Grimm; P H Vlasses
Journal:  Clin Pharm       Date:  1989-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.